Mass cytometry
Mass Cytometry
Mass cytometry is a cutting-edge technology that combines flow cytometry with mass spectrometry to enable high-dimensional single-cell analysis. This technique allows for the simultaneous measurement of multiple parameters at the single-cell level, providing researchers with a comprehensive understanding of cellular heterogeneity and function.
History[edit | edit source]
Mass cytometry was developed by a team of researchers led by Dr. Scott Tanner at Stanford University in the early 2000s. The technology was commercialized by Fluidigm Corporation under the brand name CyTOF (Cytometry by Time-Of-Flight).
Technology[edit | edit source]
Mass cytometry utilizes metal isotope-tagged antibodies to label specific cellular markers. The labeled cells are then vaporized and ionized in a mass spectrometer, where the metal tags are detected and quantified. This approach allows for the analysis of up to 50 parameters simultaneously, far exceeding the limitations of traditional flow cytometry.
Applications[edit | edit source]
Mass cytometry has revolutionized the field of immunology, enabling researchers to dissect complex immune responses with unprecedented detail. It has also found applications in cancer research, drug discovery, and personalized medicine. By profiling immune cell populations at a high resolution, mass cytometry has the potential to uncover novel biomarkers and therapeutic targets.
Challenges[edit | edit source]
Despite its numerous advantages, mass cytometry also presents challenges. The high cost of instrumentation and reagents can be a barrier for many research labs. Additionally, data analysis for high-dimensional datasets can be complex and require specialized expertise.
Future Directions[edit | edit source]
As mass cytometry continues to evolve, researchers are exploring new applications and refining existing methodologies. Advances in machine learning and computational tools are expected to streamline data analysis and interpretation, making mass cytometry more accessible to a wider scientific community.
See also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
